SocialPicks Sentiment:
** v.s.
other stocks
|
This Quarter's Sentiment:
|
|
|
HEB Analysis & Videos »
HEB: Bull or Bear?
BioMed Momentum Index: Pause that Refreshes or More Pain to Come?
HEB
|
|
|
+32.68%
in
23 days
Below is a 10-stock BioMed Momentum Index that I have created along with related financial data from Google Finance as of 10/28/09, including the stock price, 52-week change, average daily trading volume, and market cap. I have screened for small and micro-cap stocks with market caps of approximately $500 million (M) or lower with stock price increases of at least 50% in the past year and average trading volume of at least 1M shares per day. <> 1.) Antigenics (NASDAQ: AGEN) ($...
|
FDA Calendar Extreme Trades: 30 Stocks Under $5
HEB
|
|
|
+27.14%
in
89 days
(closed on 10/29/09)
<> Below are extreme trades among 30 companies with stock prices under $5 from the BioMedReports.com FDA Calendar, which includes 292 entries as of 8/1/09. The calendar was originally created by Mike Havrilla to track companies with pending new drug, biological agent, or medical device new product decisions at the FDA. With the launch of BioMedReports.com, the FDA Calendar has expanded to include the following categories: pending new submissions to the FDA (e.g. NDA, BLA, 510k, PMA, sNDA, sBLA filings), pending complete response letter (CRL) re-submissions to the FDA, and pending late-stage c...
|
FDA Calendar Extreme Trades: 30 Stocks Under $5
HEB
|
|
|
+0.00%
in
0 minute
(closed on 08/01/09)
<> Below are extreme trades among 30 companies with stock prices under $5 from the BioMedReports.com FDA Calendar, which includes 292 entries as of 8/1/09. The calendar was originally created by Mike Havrilla to track companies with pending new drug, biological agent, or medical device new product decisions at the FDA. With the launch of BioMedReports.com, the FDA Calendar has expanded to include the following categories: pending new submissions to the FDA (e.g. NDA, BLA, 510k, PMA, sNDA, sBLA filings), pending complete response letter (CRL) re-submissions to the FDA, and pending late-stage c...
|
Updated Calendar of 12 Extreme Trades on Pending FDA Decisions
HEB
|
|
|
-11.64%
in
6 days
(closed on 05/25/09)
<> Below are 12 extreme FDA trades of companies with market caps below $200M which have pending new drug product decisions or other meetings/milestones scheduled with the FDA that are expected to have a major impact on each of the underlying stock prices as the PDUFA decision dates approach and the decision is ultimately announced. A high risk/reward trading approach to consider for speculative traders is investing a small amount of money that you can afford to lose in a basket of stocks included in extreme <font> FDA and Clinical Trial Calendar </font> trades, which are highlighted in ...
|
Bullish on HEB ...
HEB
|
|
|
+88.89%
in
44 days
(closed on 06/25/09)
A PDUFA date of 5/25 sent HEB over $2 in the premarket and an $18.3 mil. offering sent it down to a low of $1.05. To me this says a guaranteed gain of at least $.70 cents over the next week and a half. Hold it through the decision if you want. Sentiments seem high. I bought into HEB after finding a four-bagger in ACUS. Too bad I don't have much time to keep up with this site.
|
Bullish on HEB ...
HEB
|
|
|
-37.13%
in
271 days
(closed on 01/30/07)
I'm actually in at 2.98 after dipping in and out once before. I hate to play fear, but with all the focus on bird flu, and the upcoming made for TV movie on the "worst case scenario" for bird flu, I expect this to take off on fear alone several times in the next few months. God help everyone should the real deal happen. but in the meantime, you might as well take advantage... HEB makes a possible solution to the limited nature of vaccines. Another stock to watch with this one is NVAX.
|
People Bullish on HEB
People Bearish on HEB
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
|
|
|
|
Biotech
(-52.08% risk: conservative)
|
|
|
More Resources
|
About Hemispherx Biopharma Inc
- Answers.com
